SavedAdd your journal

Journals / Journal of Biotechnology and Strategic Health Research / 2024 / Cilt: 8 Sayı: 3

Our Endometrial Sampling Results: Analysis of 1149 Cases

Endometri̇al Örnekleme Sonuçlarımız: 1149 Olgunun Analizi

Serdar Çimen(Sakarya Eğitim ve Araştırma Hastanesi)0000-0002-1655-5807
Emin Levent Aksoy(Sakarya Eğitim ve Araştırma Hastanesi)0000-0002-4862-1231
Mehmet Musa Aslan(Yalova Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Anabilim dalı)0000-0002-7830-5002
Pages
218–223
Publication Date
2024-12-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, we could not find results that support routine preoperative sampling in patients undergoing hysterectomy for benign reasons.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study, we aimed to investigate the relationship between the indications and histopathological results in endometrial sampling performed in our clinic, which is a tertiary center.
📊
Key Findings & Data:Material and Method: Pathology results of 1149 patients who underwent endometrial sampling for gynecological reasons at Sakarya Training and Research Hospital between January 2015 and March 2021 were evaluated retrospectively.
💡
Conclusion & Impact:However, we could not find results that support routine preoperative sampling in patients undergoing hysterectomy for benign reasons.
🔬Design:Araştırma Makalesi
📍Scope:2015 Verileri
⚙️Variables:Endometrial örnekleme · Anormal uterin kanama · Endometrium kanseri

Abstract

Aim: In this study, we aimed to investigate the relationship between the indications and histopathological results in endometrial sampling performed in our clinic, which is a tertiary center. Material and Method: Pathology results of 1149 patients who underwent endometrial sampling for gynecological reasons at Sakarya Training and Research Hospital between January 2015 and March 2021 were evaluated retrospectively. The cut-off value for postmenopausal endometrial thickness increase was accepted as 5 mm. Results: The mean age of the patients was 47.58. 813(70.8%) of them were in the premenopausal period and 336 (29.2%) of them were in the postmenopausal period. The most common indication for endometrial sampling was abnormal uterine bleeding. It was observed that patients with postmenopausal bleeding were the most at-risk group for endometrial cancer. Conclusion: Endometrial sampling would be an appropriate approach in patients with abnormal uterine bleeding, postmenopausal bleeding, increased postmenopausal endometrial thickness, and those using tamoxifen, which are at increased risk of endometrial cancer. However, we could not find results that support routine preoperative sampling in patients undergoing hysterectomy for benign reasons.

Özet

Amaç: Bu çalışmamızda tersiyer bir merkez olan kliniğimizde yapılan endometrial örneklemelerde endikasyonlar ve histopatolojik sonuçlar arasındaki ilişkiyi araştırmayı amaçladık. Gereç ve Yöntem: Sakarya Eğitim ve Araştırma Hastanesinde Ocak 2015- Mart 2021 tarihleri arasında jinekolojik nedenler ile endometrial örnekleme yapılan 1149 hastanın patoloji sonuçları retrospektif olarak değerlendirildi. Postmenopozal endometrial kalınlık artışı için sınır değer 5 mm olarak kabul edildi. Bulgular: Çalışmaya dahil olan hastaların yaş ortalaması 47,58 idi. 813(%70,8) tanesi premenopozal dönemdeyken, 336(%29,2) tanesi postmenopozal dönemdeydi. Endometrial örnekleme için en sık endikasyonun anormal uterin kanama olduğu izlendi. Endometrium kanseri için ise en riskli grubu postmenopozal kanaması olan hastalar oluşturduğu izlendi. Sonuç: Endometrium kanseri riskinin arttığı anormal uterin kanama, postmenepozal kanama, postmenepozal endometrial kalınlık artışı olan ve tamoksifen kullanan hastalarda endometrial örnekleme yapılması uygun bir yaklaşım olacaktır. Bunula beraber beningn nedenlerle histerektomi yapılcak hastalara preopretif rutin örnekleme yapılmasını destekler sonuçlara ulaşamadık.

🔖

Cite This Article

Çimen, S., Aksoy, E. L., Aslan, M. M. (2024). Our Endometrial Sampling Results: Analysis of 1149 Cases. Journal of Biotechnology and Strategic Health Research, Cilt: 8 Sayı: 3, 218–223. https://doi.org/10.34084/bshr.1582866

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Seebacher V, Schmid M, Polterauer S, et al. The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study. BMC Cancer. 2009;9:460. Published 2009 Dec 22. doi:10.1186/1471-2407-9-460
  2. Grimes DA. Diagnostic dilation and curettage: a reappraisal. Am J Obstet Gynecol. 1982;142(1):1-6. doi:10.1016/s0002-9378(16)32276-1
  3. Inal ZO, Inal HA, Kucukosmanoglu I, et al. Assessment of Endometrial Sampling and Histopathological Results: Analysis of 4,247 Cases. Eurasian J Med. 2017;49(1):44-47. doi:10.5152/eurasianjmed.2017.16269
  4. Shrestha DB, Thapa S, Singh R, et al. Presenting complaints in Gynecology Outpatient Department (OPD) and prevalence and assessment of dysmenorrhea. Medical Journal of Shree Birendra Hospital. 2017;16(1):47-51. doi:10.3126/mjsbh.v16i1.16027
  5. Kucur SK, Şencan H, Yüksel KB, et al. Endometri̇al örnekleme sonuçlarımız:744 Olgunun analizi (evaluation of endometrial biopsy results in our clinic; analysis of 744 cases). Zeynep Kamil Tıp Bülteni. 2014;45(3):146. doi:10.16948/zktb.68266
  6. Çakmak B.,Karataş A.,Turan G.Endometrial Örnekleme Sonuçlarımız: 400 Olgunun Analizi,Selçuk Tıp Dergisi 2012, Vol. 28(3)
  7. Clarke MA, Long BJ, Del Mar Morillo A, et al. Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis. JAMA Intern Med. 2018;178(9):1210-1222. doi:10.1001/jamainternmed.2018.2820
  8. Tofiloska V, Velik-Stefanovska V, Dimitrov G. The Connection between the Endometrial Thickness and the Risk of Endometrial Malignancy in Postmenopausal Women. Open Access Maced J Med Sci. 2019;7(14):2263-2266. Published 2019 Jul 28. doi:10.3889/oamjms.2019.639
  9. Timmermans A, Opmeer BC, Khan KS, et al. Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstet Gynecol.2010;116(1):160-167. doi:10.1097/AOG.0b013e3181e3e7e8
  10. Gupta JK, Chien PF, Voit D, et al. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand. 2002;81(9):799-816. doi:10.1034/j.1600-0412.2001.810902.x
  11. Hanligil E, Ekici MA. Is it necessary to perform an endometrial sampling prior to hysterectomies for benign conditions. Experimental Biomedical Research. 2019;2(2):76-84. doi:10.30714/j-ebr.2019250353
  12. Committee Opinion No. 601: Tamoxifen and uterine cancer. Obstet Gynecol. 2014;123(6):1394-1397. doi:10.1097/01.AOG.0000450757.18294.cf
  13. Turhan Çakır A, Öz İ, Ün B. Endometri̇al Örnekleme Sonuçlarımız: 365 Olgunun Analizi. Bozok Tıp Dergisi. doi:10.16919/bozoktip.539875
  14. Khare A, Bansal R, Sharma S, et al. Morphological spectrum of Endometrium in patients presenting with Dysfunctional Uterine Bleeding. People’s Journal of Scientific Research. 2012;5:13-16.
  15. Jetley S, Rana S, Jairajpuri ZS. Morphological spectrum of endometrial pathology in middle-aged women with atypical uterine bleeding: A study of 219 cases. J Midlife Health. 2013;4(4):216-220. doi:10.4103/0976-7800.122242
  16. Kucur SK, Şencan H, Yüksel KB, et al. Endometri̇al örnekleme sonuçlarımız:744 Olgunun analizi (evaluation of endometrial biopsy results in our clinic; analysis of 744 cases). Zeynep Kamil Tıp Bülteni. 2014;45(3):146. doi:10.16948/zktb.68266
  17. Khare A, Bansal R, Sharma S, et al. Morphological spectrum of Endometrium in patients presenting with Dysfunctional Uterine Bleeding. People’s Journal of Scientific Research. 2012;5:13-16.